SREBP-1c mediates the insulin-dependent hepatic glucokinase expression

被引:84
|
作者
Kim, SY
Kim, HI
Kim, TH
Im, SS
Park, SK
Lee, IK
Kim, KS
Ahn, YH
机构
[1] Dept Biochem & Mol Biol, Seoul 120752, South Korea
[2] Brain Korea 21 Project Med Sci, Seoul 120752, South Korea
[3] Ctr Chron Metab Dis Res, Seoul 120752, South Korea
[4] Inst Genet Sci, Seoul 120752, South Korea
[5] Keimyung Univ, Sch Med, Dept Internal Med, Taegu, South Korea
关键词
D O I
10.1074/jbc.M313223200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The regulation of hepatic glucose metabolism is important in glucose homeostasis, and liver glucokinase (LGK) plays a central role in this process. Hepatic glucokinase expression is known to be regulated by insulin. Recently it has been suggested that sterol regulatory element binding protein-1c (SREBP-1c) mediates the action of insulin on LGK transcription; however, the precise mechanism is not, to date, well known. In the present study, we identified two functional SREBP-1c response elements, SREa and SREb, in the rat LGK promoter. SREBP-1c could bind to these SREs and activate the LGK promoter, and insulin activated the LGK promoter in Alexander cells. The physical interaction between the protein and SREs of the LGK promoter in vivo was also confirmed. Insulin selectively increased SREBP-1c and LGK expression in primary hepatocytes. Adenoviral expression of SREBP-1c stimulated LGK expression, and the dominant negative mutant of SREBP-1c blocked the increased gene expression of LGK by insulin and SREBP-1c. A chromatin immunoprecipitation assay using primary hepatocytes showed increased binding of SREBP-1 to SREs of the LGK promoter by insulin.
引用
收藏
页码:30823 / 30829
页数:7
相关论文
共 50 条
  • [11] INSULIN-DEPENDENT SYNTHESIS OF GLUCOKINASE
    SOLS, A
    SILLERO, A
    SALAS, J
    JOURNAL OF CELLULAR AND COMPARATIVE PHYSIOLOGY, 1965, 66 (2S1P): : 23 - &
  • [12] Effects of Retinoids on Insulin Secretion and Expression of Srebp-1c in INS-1 Cells
    Chen, Wei
    Li, Rui
    Li, Yang
    Chen, Guoxun
    DIABETES, 2011, 60 : A705 - A705
  • [13] ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose
    Foretz, M
    Pacot, C
    Dugail, I
    Lemarchand, P
    Guichard, C
    Le Lièpvre, X
    Berthelier-Lubrano, C
    Spiegelman, B
    Kim, JB
    Ferré, P
    Foufelle, F
    MOLECULAR AND CELLULAR BIOLOGY, 1999, 19 (05) : 3760 - 3768
  • [14] Insulin inhibition of hepatic gene expression involves the transcription factor sterol regulatory element binding protein-1c (SREBP-1c).
    Foufelle, F
    Chakravarty, K
    Leahy, P
    Foretz, M
    Hanson, RW
    Ferre, P
    DIABETOLOGIA, 2000, 43 : A45 - A45
  • [15] SREBP-1c and TFE3, energy transcription factors that regulate hepatic insulin signaling
    Hitoshi Shimano
    Journal of Molecular Medicine, 2007, 85 : 437 - 444
  • [16] SREBP-1c and TFE3, energy transcription factors that regulate hepatic insulin signaling
    Shimano, Hitoshi
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2007, 85 (05): : 437 - 444
  • [17] Dexamethasone potentiates the insulin-induced Srebp-1c expression in primary rat hepatocytes
    Yan Zhang
    Xiangming Fang
    Fen Shuang
    Guoxun Chen
    Food Science and Human Wellness, 2023, 12 (05) : 1519 - 1525
  • [18] Dexamethasone potentiates the insulin-induced Srebp-1c expression in primary rat hepatocytes
    Zhang, Yan
    Fang, Xiangming
    Shuang, Fen
    Chen, Guoxun
    FOOD SCIENCE AND HUMAN WELLNESS, 2023, 12 (05) : 1519 - 1525
  • [19] Electromagnetic Fields Ameliorate Insulin Resistance and Hepatic Steatosis by Modulating Redox Homeostasis and SREBP-1c Expression in db/db Mice
    Zhai, Mingming
    Yan, Xi
    Liu, Jiangzheng
    Long, Zi
    Zhao, Siyan
    Li, Wendan
    Liu, Ying
    Hai, Chunxu
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2021, 14 : 1035 - 1042
  • [20] Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet
    Muraoka, Tomonori
    Aoki, Kazutaka
    Iwasaki, Tomoyuki
    Shinoda, Kazuaki
    Nakamura, Akinobu
    Aburatani, Hiroyuki
    Mori, Shuuichi
    Tokuyama, Kumpei
    Kubota, Naoto
    Kadowaki, Takashi
    Terauchi, Yasuo
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2011, 60 (05): : 617 - 628